- Home
- LIXT vs MRM Comparison
LIXT vs MRM Comparison
Compare LIXT & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- MRM
- Stock Information
- Founded
- LIXT 2005
- MRM 2000
- Country
- LIXT United States
- MRM Japan
- Employees
- LIXT N/A
- MRM N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- MRM Other Consumer Services
- Sector
- LIXT Health Care
- MRM Consumer Discretionary
- Exchange
- LIXT Nasdaq
- MRM Nasdaq
- Market Cap
- LIXT 12.4M
- MRM 10.4M
- IPO Year
- LIXT N/A
- MRM 2020
- Fundamental
- Price
- LIXT $5.63
- MRM $1.85
- Analyst Decision
- LIXT
- MRM
- Analyst Count
- LIXT 0
- MRM 0
- Target Price
- LIXT N/A
- MRM N/A
- AVG Volume (30 Days)
- LIXT 167.8K
- MRM 1.5M
- Earning Date
- LIXT 11-11-2025
- MRM 11-11-2025
- Dividend Yield
- LIXT N/A
- MRM N/A
- EPS Growth
- LIXT N/A
- MRM 27.65
- EPS
- LIXT N/A
- MRM 0.18
- Revenue
- LIXT N/A
- MRM $52,786,758.00
- Revenue This Year
- LIXT N/A
- MRM N/A
- Revenue Next Year
- LIXT N/A
- MRM N/A
- P/E Ratio
- LIXT N/A
- MRM $9.92
- Revenue Growth
- LIXT N/A
- MRM 21.55
- 52 Week Low
- LIXT $0.64
- MRM $0.34
- 52 Week High
- LIXT $6.26
- MRM $5.30
- Technical
- Relative Strength Index (RSI)
- LIXT 65.38
- MRM 52.46
- Support Level
- LIXT $5.40
- MRM $1.73
- Resistance Level
- LIXT $6.26
- MRM $2.02
- Average True Range (ATR)
- LIXT 0.63
- MRM 0.20
- MACD
- LIXT 0.14
- MRM -0.00
- Stochastic Oscillator
- LIXT 78.28
- MRM 55.84
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.